YouTube Facebook LinkedIn Google+ Twitter Xinginstagram rss  
  • Tsetse Genome
  • Virome
  • EyeWire Banner
  • 23 and Me
  • Toumazou
  • DeepGenomics
Thermo Fisher Clarifies Its Vision for Sequencing with Release of Ion S5 Instruments
TODAY | Bio-IT World | Thermo Fisher Scientific, which owns the Ion Torrent line of next-generation sequencing instruments, announced today that two new sequencers are being added to its portfolio, with a special emphasis on targeted sequencing in areas like oncology, rare disease, and gene expression. more

FDA Settles on Policy for Generic Names of Biosimilars
TODAY | BioPharma Reporter | The FDA has published long-awaited guidelines on the non-proprietary naming of biological products, but biosimilar makers say adding a random four-letter suffix could needlessly complicate the prescribing system. more

Rgenix Scores Rare Multimillion Dollar Funding Round for New York Biotech Scene
| Xconomy | The startup company has raised $8 million in new capital to develop drugs based on a discovery program that searches for targets by measuring microRNA expression in cancer. more

PrecisionFDA to Test Accuracy of Genomic Analysis Tools
| Bio-IT World | The FDA has contracted with DNAnexus to build an open web portal where researchers working on new genomic tests can evaluate their computational workflows, testing them on real and simulated DNA data and comparing them against industry standards. more

Florida Experience with Scripps Illustrates Difficulty of Building a Biotech Cluster from the Top Down
| Los Angeles Times | Jeb Bush's presidential run has brought renewed attention to one of the headline achievements of his tenure as governor of Florida: luring a new Scripps Research Institute campus to the state. more

Former Director of Clinical Pharmacology at CDER Appointed to Certara’s Simcyp Scientific Advisory Board
| PRINCETON, NJ - Aug 20, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that Lawrence J more

Ashion Analytics™ launches genomic testing services designed to improve cancer care
| PHOENIX, AZ, UNITED STATES - Aug 19, 2015 - Ashion Analytics, a CLIA certified and CAP-accredited molecular cancer testing laboratory, today announced its launch and the availability of its flagship product, the Genomic Enabled Medicine (GEM) Cancer Panel™ , to assist doctors in treating patients with cancer more

Boston Medical Center Selects PFS Clinical for Coverage Analysis of Clinical Research Trials
| MIDDLETON, WI, UNITED STATES - Aug 18, 2015 - PFS Clinical, which offers turnkey administration solutions that address the key pain points of establishing and running a clinical trial office, has been engaged by the Boston Medical Center (BMC) Clinical Trial Office to provide Medicare Coverage Analysis (CA) of its clinical research trials more

Veracyte, Inc. Appoints Dr. Neil M. Barth as Chief Medical Officer
| SOUTH SAN FRANCISCO, CA, UNITED STATES - Aug 17, 2015 - Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced the appointment of Neil M more

Cloud Pharmaceuticals Strengthens Management Team with Appointment of Two C-Level Executives
| RESEARCH TRIANGLE PARK, NC - Aug 17, 2015 - Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, today announced the appointment of two C-level executives to its management team more

Certara Senior Scientific Advisor and Head of Simcyp Translational Science Dr. Iain Gardner Appointed to Xenobiotica Editorial Board
| PRINCETON, NJ - Aug 10, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that Iain Gardner, Ph more

Punctuating Messages Encoded in Human Genome with Transposable Elements
| SAN FRANCISCO, CA, UNITED STATES - Aug 4, 2015 - Since the classical studies of Jacob and Monod in the early 1960s, it has been evident that genome sequences contain not only blueprints for genes and the proteins that they encode, but also the instructions for a coordinated regulatory program that governs when, where and to what extent these genes and proteins are expressed more

Rancho BioSciences and BT to Provide Big Data Cloud Services to Life Sciences Sector
| SAN DIEGO, CA, UNITED STATES - Jul 14, 2015 - Rancho BioSciences, the Data Curation Company, today announced that they will work with BT to provide cloud-based data curation services to their joint customers more

Creative Bioarray Introduces Whole Chromosome Painting Probes to Biological Researchers
| NEW YORK, NY - Jul 20, 2015 - Creative Bioarray, an innovative biotechnology company who supplies research-use cells, cell culture medium and reagents, FISH probes, tissue array, microorganisms, equipments and related services, etc, has announced its Whole Chromosome Painting Probes to bio-research community more

Synexus continues expansion across Eastern Europe with three new clinical trial centres
| CHORLEY, UNITED KINGDOM - Jul 15, 2015 - Synexus continues to expand across Eastern Europe with three new Dedicated Research Centres in Bulgaria, Poland and Romania, bringing the total to nine centres in Eastern Europe and a total network of 25 across Europe and Africa more



As data volumes grow and scientific advances require more compute power, life sciences organizations need more powerful, lower-cost solutions to meet demand. IBM Software Defined Infrastructure (SDI) featuring IBM® Platform Computing™ helps clients increase their competitive advantage by using an agile, high-performance, shared infrastructure resulting in faster time-to-results for analytics and collaboration across the research and development ecosystem.

IBM® is a global technology company that develops and sells software and systems including a broad range of infrastructure, IBM SoftLayer®cloud and consulting services in more than 170 countries. Along with its life sciences industry partners, IBM enables its clients to accelerate time-to-value with powerful IBM Power® and storage systems designed to accelerate and optimize life science workloads.

Product Highlights: Validated by App Developers, Out-of-box Performance, Support and Consultation, Fully Customizable


Exxact Certified Life Science GPU Systems
Exxact designs a series of certified life science GPU systems in collaboration with life science software developers to provide value-add turnkey solutions for optimizing the scientific workflow and accelerating the pace of research. Each system is ready to run out of the box and capable of accelerating complex bioscience codes, in fields encompassing, drug discovery, biocatalyst design, molecular biology, bioinformatics and materials science.

Product Highlights:

  • Validated by App Developers
  • Out-of-box Performance
  • Support and Consultation
  • Fully Customizable

Visit to learn more about the certified life science systems and case study.

Bio IT World Lead Gen  

Upcoming Industry Events and Webinars

 Upcoming Webinars  

Data Integration in Life Science – Are You Ready? |
Thu, May 1 at 1 pm EST | Sponsored by YarcData  

Ready...Set...Collaborate--Saving Millions with Faster Time to Market |
Thu, May 15 at 11 am EST | Sponsored by Exostar 

Redefining Targeted Sequencing: Complete Coverage of Targeted Regions via an Innovative Massively-Parallel Singleplex PCR Enrichment |

Wed, May 28 at 1 pm EST | Sponsored by Wafergen

Genome-Phenome Analysis |
Wed, June 25 at 1 pm EST  | Sponsored by SimulConsult

Recorded Webinars 

How TGen is Applying High Performance Computing to Accelerate Cancer Research 
Sponsored by Terascala

An Integrated Platform for All Translational Medicine Data: Using Visual Analytics and Tibco Spotfire to Enhance Personalized Medicine and Translational Science  
Sponsored by PerkinElmer 

Trends in BioIT Data Management & Storage 
Sponsored by Avere Systems 

Big Bioinformatics and Healthcare Analytics without Big Hassles 
Sponsored by Paradigm4

Manage Complexity by Visual Data Exploration 
Sponsored by Qlucore

Digital Signatures in the Enterprise
Sponsored by ARX 

Complete Webinar Listing 


Upcoming Events 

Bio-IT World Conference & Expo
April 29- May 1, 2014 • Boston, MA

BIOtech 2014 in Japan
May 14-16, 2014  • Tokyo, Japan

2nd Annual Next Generation Sequencing Data Congress
May 19-20, 2014 • London, UK

14th Annual Structure-Based Drug Design
May 21-22, 2014 • Boston, MA

15th Annual Drug Discovery Leaders Summit 2014
June 2-3, 2014 • Geneva, Switzerland

6th Annual Drug Development Congress 2014
June 2-3, 2014 • Geneva, Switzerland

2nd Annual Discovery Chemistry & Drug Design Congress 2014
June 2-3, 2014 • Geneva, Switzerland

Conference on Translational Medicine
September 22-25, 2014 • Vienna, Austria

4th Annual Next Generation Sequencing Asia Congress 2014
October 7-8, 2014 • Singapore

2nd Annual Single Cell Genomics & Transcriptomics Asia Congress 2014
October 7-8, 2014 • Singapore

6th Annual Next Generation Sequencing Congress 2014
November 2014 • UK


Complete Event Listing 

Free Downloads: Whitepapers, Podcasts and More


Related Products

BIOVIA’s ScienceCloud  BIOVIA’s ScienceCloud 

The BIOVIA Biologics Solution  The BIOVIA Biologics Solution 

Cloud: Not Just for the Big Guys - How Small to Medium Businesses are Leveraging Cloud to Accelerate R & D Efforts

November 13 at 11am EST  |  Register Today to Reserve Your Space Sponsored by    It is no surprise that authors place what they consider to be their most important and promising findings into an abstract. But as an abstract’s size

For reprints and/or copyright permission, please contact Terry Manning, 781.972.1349.